Efficacy of lenvatinib plus pembrolizumab in hepatocellular carcinoma with metachronous lung metastasis: a report of two cases

CONCLUSIONS: The findings of the current study and recently published data indicate lung metastasis as a potential clinical therapeutic indicator for efficacy of immunotherapy against HCC.PMID:34296632 | DOI:10.1177/03008916211033353

Source: Tumori - July 23, 2021 Category: Cancer & Oncology Authors: JieLang Li Ting Chen Feng Bi Yu Yang Source Type: research